ArticleResearch square2025
Turbulent-like Dynamics Predict Treatment Outcome in Major Depressive Disorder.
Article in Research square, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
introductionMajor depressive disorder is a prevalent and debilitating disease. Finding effective treatment is a lengthy trial-and-error process. Thus, identifying predictors of treatment outcome is key to reducing disease burden. Brain turbulence-like dynamic measures on transmission of information might be a potential methodological strategy for identifying informative predictors of antidepressant treatment response.
methodsWe analyzed data of the EMBARC study in which 296 adult outpatients were randomized to eight weeks of sertraline or placebo treatment. Resting state functional MRI scans were acquired at baseline and one week after treatment initiation. Turbulence-like dynamic measures were computed. Generalized linear models were used to predict week 8 response and symptom severity scores. Primary performance metrics were the area under the receiver operating characteristic (AUROC) and the root mean squared error (RMSE) respectively. Permutation testing was performed to test for significance against chance. Internal leave-one-out cross-validation was performed on the sertraline-treated patients (sample A) and external validation on the placebo arm (sample B) and on placebo-treated, non-responding patients who later switched to sertraline (sample C).
results226 patients were analyzed (age 37.9±13.4 years; 148 [65.5%] female). Sample A included 109 participants, sample B 121, and sample C 61. Internal cross-validation results were significantly better than chance at predicting response (AUROC=0.71, balanced accuracy=69.5%, p=0.008) and symptom severity (RMSE=4.7, p=0.025). External validation in sample B did not yield performance significantly better than chance, and in sample C only prediction of response did (AUROC=0.65, balanced accuracy=60.3%, p=0.038).
conclusionThe turbulence framework is a suitable paradigm for predicting sertraline response in major depressive disorder. Prediction specificity to sertraline treatment was limited. Non-responders to sertraline were characterized by increased long-distance and reduced short-distance information cascade flow.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.